2m 2m 2m 2m 2m 2m 2m
NEWAMST PH CO (NAMS)
NASDAQ
$31.41+$0.59 (+1.90%)
Price as of Jun 23, 2026 6:29 PM EDT- $3.5BMarket Cap
- 69.25%1-Year Change
- BiotechnologyIndustry
NEWAMST PH CO (NAMS)
$31.41+$0.59 (+1.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 22.5M -50.61% | 45.6M +223.37% | 14.1M -85.55% | 97.5M N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 3.1M N/A | |
Gross Profit | 22.5M -50.61% | 45.6M +223.37% | 14.1M -85.07% | 94.4M N/A | |
Sales and Marketing Expense | 106.4M +50.97% | 70.4M +87.19% | 37.6M +69.29% | 22.2M N/A | |
Research and Development Expense | -141.8M -6.32% | -151.4M -5.03% | -159.4M +93.88% | -82.2M N/A | |
Depreciation and Amortization Expense | 220,000 +94.69% | 113,000 +130.61% | 49,000 -31.94% | 72,000 N/A | |
Total Operating Expenses | 248.2M +11.87% | 221.9M +12.58% | 197.1M +786.45% | 22.2M N/A | |
Operating Profit | -225.7M +28.02% | -176.3M -3.65% | -183.0M +170.82% | -67.6M N/A | |
Interest Income | 27.6M +63.45% | 16.9M +49.61% | 11.3M N/A | N/A N/A | |
Interest Expense | N/A N/A | -287,000 0.00% | -287,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 27.6M +66.28% | 16.6M +50.91% | 11.0M N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | 287,000 0.00% | 287,000 N/A | N/A N/A | |
Income before Taxes | -203.8M -15.64% | -241.6M +36.57% | -176.9M +126.66% | -78.1M N/A | |
Income Taxes | -1,000 0.00% | -1,000 -103.70% | 27,000 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -203.8M -15.64% | -241.6M +36.54% | -176.9M +126.69% | -78.1M N/A | |
Net Income from Continuing Operations Applicable to Common | -203.8M -15.64% | -241.6M +36.57% | -176.9M +126.66% | -78.1M N/A | |
Basic EPS and Net Income | -1.72 -32.81% | -2.56 +19.07% | -2.15 +9.14% | -1.97 N/A | |
Diluted EPS and Net Income | -1.72 -32.81% | -2.56 +19.07% | -2.15 +9.14% | -1.97 N/A | |
Basic Weighted Average Shares | 118.4M +25.51% | 94.4M +14.84% | 82.2M +107.33% | 39.6M N/A | |
Diluted Weighted Average Shares | 118.4M +25.51% | 94.4M +14.84% | 82.2M +107.33% | 39.6M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 490.0M -36.51% | 771.7M +126.68% | 340.4M -22.36% | 438.5M N/A | |
Short-Term Investments | 146.2M +134.18% | 62.4M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 636.2M -23.73% | 834.2M +145.03% | 340.4M -22.36% | 438.5M N/A | |
Total Current Assets | 675.7M -21.74% | 863.4M +148.97% | 346.8M -22.61% | 448.1M N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 383,000 +58.26% | 242,000 +426.09% | 46,000 -68.06% | 144,000 N/A | |
Total Long-Term Assets | 93.0M +38,326.45% | 242,000 +426.09% | 46,000 -99.94% | 83.5M N/A | |
Total Assets | 769.3M -11.03% | 864.6M +149.10% | 347.1M -34.71% | 531.6M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 85.8M -19.76% | 106.9M +114.28% | 49.9M +40.71% | 35.5M N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 66,000 -99.27% | 9.0M +1.60% | 8.9M -23.57% | 11.6M N/A | |
Total Liabilities | 85.9M -19.85% | 107.1M +82.47% | 58.7M N/A | N/A N/A | |
Retained Earnings | -762.4M +36.49% | -558.6M +76.22% | -317.0M N/A | N/A N/A | |
Total Stockholders Equity | 683.4M -9.78% | 757.5M +162.66% | 288.4M -40.48% | 484.5M N/A | |
Total Shares Outstanding | 114.4M +5.86% | 108.1M +31.04% | 82.5M +1.12% | 81.6M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -147.8M -6.80% | -158.6M +12.28% | -141.2M -1,871.42% | 8.0M N/A | |
Capital Expenditures | 246,000 -63.39% | 672,000 +2,700.00% | 24,000 N/A | N/A N/A | |
Cash from Investing Activities | -174.9M +178.32% | -62.8M +261,766.67% | -24,000 -103.36% | 715,000 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 29.5M -95.52% | 659.5M +7,300.21% | 8.9M -97.62% | 375.2M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,002.90% +159.21% | -386.91% -70.20% | -1,298.56% N/A | N/A N/A | |
Return on Assets | -24.95% -37.44% | -39.88% -0.98% | -40.27% N/A | N/A N/A | |
Return on Equity | -28.29% -38.77% | -46.20% +0.91% | -45.78% N/A | N/A N/A | |
Revenue Growth | -50.61% -122.66% | 223.37% +361.10% | -85.55% N/A | N/A N/A | |
Current Ratio | 7.88 -2.46% | 8.08 +16.19% | 6.95 N/A | N/A N/A | |
Cash Ratio | 5.71 -20.87% | 7.22 +5.79% | 6.82 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow